Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00135369
Status:
COMPLETED
Last Update Posted:
2011-04-25
First Post:
2005-08-25
Brief Title:
Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment HAART Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb